A Seattle-based venture capitalist has successfully raised $6.6 million for a new fund targeting women’s health and wealth startups, significantly exceeding initial fundraising expectations despite challenging market conditions.
Swizzle Ventures, founded by Jessica Kamada, plans to distribute investments across approximately 30 companies, with individual investments ranging from $100,000 to $200,000. The fund has already backed 10 ventures, including Seattle’s Trellis Health, a pregnancy tracking platform that completed the Techstars Seattle program in 2023.
Kamada’s unconventional path to venture capital has proven to be an asset rather than a liability. With over eight years of experience at Seattle marketing agency Bamboo, she developed expertise in scaling consumer tech companies, many of which achieved successful exits through acquisitions or public offerings. This background in growth marketing has become a key differentiator for Swizzle Ventures.
The fund’s focus on women’s health aligns with significant market opportunities identified by major consulting firms. McKinsey research suggests there is $1 trillion in economic potential connected to improvements in women’s health and economic participation.
Additionally, Boston Consulting Group has highlighted that while women control most discretionary spending, they remain underserved by existing products and services.
The current political climate, including debates surrounding women’s healthcare access and DEI initiatives, has unexpectedly created additional opportunities for innovation in areas such as maternal care and remote monitoring. Kamada noted increased investor interest following the November U.S. elections, with one of Swizzle’s portfolio companies – a women-focused social search platform – experiencing substantial user growth.
Among Swizzle’s investments are Mavida Health, which provides maternal mental healthcare services, and Alinea, an artificial
intelligence-powered investment management platform designed for Gen Z women. Kamada expressed particular enthusiasm about AI’s potential to revolutionize healthcare through personalization, enabling the development of individualized treatment protocols based on multiple variables.
The fund has attracted a diverse group of limited partners, including former Providence Health executives, professional athletes from both the NFL and WNBA, and growth leaders from major tech companies such as Meta, Google, and Uber. Healthcare industry veteran Ashley Lieser serves as venture partner, bringing extensive leadership experience from organizations including WPS, Optum, Prospero Health, and Blue Cross Blue Shield.
Despite being a first-time fund manager launching during a period of venture capital contraction, Kamada managed to raise more than double her initial target. She attributes this success partly to the growing recognition of opportunities in women’s health, supported by emerging research and increasing market demand.
Recent advances in women’s health research have created what Kamada sees as a ground-floor opportunity for investors. The combination of new scientific understanding, technological capabilities, and market demand positions the sector for significant growth and innovation.
Swizzle Ventures maintains a national investment scope, considering opportunities across the United States rather than limiting itself to a specific region. This broad geographic focus allows the fund to identify and support promising companies regardless of location, while maintaining its specialized focus on women’s health and wealth solutions.
The successful launch of Swizzle Ventures demonstrates both the growing recognition of opportunities in women’s health innovation and the ability of non-traditional venture capitalists to attract significant investment by highlighting their unique perspectives and expertise.